Unlocking Access to Clinical Trial Data What Are We Afraid of? HuffPost Tech UK by James Shannon GlaxoSmithKline’s Chief Medical Officer 3 September 2013 Today thousands of people all over the world will take part in clinical trials. Why do they volunteer, willingly sacrifice their time and in some cases experience discomfort and inconvenience? Of […]
After thinking about that last post, I tried to sit in Neal Parker’s of AbbVie’s shoes and feel his perspective. AbbVie sued when a rival petitioned for their clinical trial data. One of the tools of empathy is to try to think of a situation in your own life that matches the position of the […]
I apologize in advance for the length of this quote. This BMJ News article is posted on David Healy’s site as part of his post entitled Trade Wars we have known and loved: AbbVie v China. I’ve reposted it here because I found the PDF too blurry and I think it’s something everyone will want […]
Did you ever notice how quickly resolutions melt in the face of temptation? I had resolved that I wouldn’t lurk in wait for everything Dr. Lieberman writes so I can attack it as a way to protest the way his APA is running these days. I did pretty well until I got to the paragraphs […]
tar·get [tärgt] noun Something aimed or fired at. nov·el [nvl] adjective. Strikingly new, unusual, or different. I suppose a slang can arise almost anywhere. Until I started nosing around the tangles in psychiatric medications a few years back, I’d never heard these words used as I hear them now, certainly not in tandem – eg […]
[Note: Dates corrected] Back in January 2012, I wrote about Australian Depression/Sleep Guru, Ian Hickie, who had published an article in the August 2011 Lancet reviewing the studies of Agomelatine as an antidepressant positively [Novel melatonin-based therapies: potential advances in the treatment of major depression] to an international outcry of protest [of sound and fury…, […]
I can see that neither Jack Friday [Pharmagossip], our man on ChinaGate, nor the Chinese central authority took the weekend off to celebrate the US Labor Day: Reforms urged for pharma industry CHINADAILY USA By XU WEI 2013-09-04 Experts have called for reforms of public hospitals and more legislation on the pharmaceutical industry, after police […]
as long as I resist you, I live… In Bergman’s classic 1957 allegory, The Seventh Seal, a disillusioned knight returns from the Crusades to a Sweden under the grip of the Plague, only to encounter the personification of Death who has come for him. He challenges Death to a game of chess, played for his […]
Schizophrenia Is a Cognitive Illness: Time for a Change in Focus. by Kahn RS and Keefe RS. JAMA Psychiatry. 2013 Aug 7. doi: 10.1001/jamapsychiatry.2013.155. [Epub ahead of print] Schizophrenia is currently classified as a psychotic disorder. This article posits that this emphasis on psychosis is a conceptual fallacy that has greatly contributed to the lack […]
Antipsychotics: Taking the Long View NIMH Director’s Blog By Thomas Insel August 28, 2013 One of the first lessons I received as a psychiatrist-in-training 35 years ago was the value of antipsychotic medications. These medicines have been available for the treatment of psychosis for over half a century, beginning with the prototype first generation drug […]